InsidersTradesSigma
Track the 진양제약 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 진양제약 has published 3 reports. Market capitalisation: €53.4bn. The latest transaction was reported on 5 June 2026 (Sale). Among the most active insiders: 최재준. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Jinyang Pharmaceutical 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于药品的研发和制造。